(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide

License

No License Provided

Export

DCAT-AP(rdf/xml) DCAT-AP(ttl) DCAT-AP(jsonld) DCAT-AP-PLUS(xml) DCAT-AP-PLUS(tll) DCAT-AP-PLUS(jsonld)

Schema.Org(rdf/xml) Schema.Org(xml) Schema.Org(ttl) Schema.Org(jsonld)

Molecule

(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide

Chemical Information

15 Related Dataset(s) ⌄

Amikacin; LC-ESI-Q; MS; NEG; 15 V

Amikacin; LC-ESI-Q; MS; NEG; 30 V

Amikacin; LC-ESI-Q; MS; NEG; 45 V

Amikacin; LC-ESI-Q; MS; NEG; 60 V

Amikacin; LC-ESI-Q; MS; NEG; 75 V, 90 V

Amikacin; LC-ESI-Q; MS; POS; 15 V

Amikacin; LC-ESI-Q; MS; POS; 30 V

Amikacin; LC-ESI-Q; MS; POS; 45 V

Amikacin; LC-ESI-Q; MS; POS; 60 V

Amikacin; LC-ESI-Q; MS; POS; 75 V, 90 V

Amikacin; LC-ESI-QQ; MS2; CE:10 V; [M+H]+

Amikacin; LC-ESI-QQ; MS2; CE:20 V; [M+H]+

Amikacin; LC-ESI-QQ; MS2; CE:30 V; [M+H]+

Amikacin; LC-ESI-QQ; MS2; CE:40 V; [M+H]+

Amikacin; LC-ESI-QQ; MS2; CE:50 V; [M+H]+

Metadata Information

Field	Value
NFDI4Chem Molecule ID	nfdi4chem-mol65743
Source
Alternate Name

Field	Value
No additional information available for this Dataset.

Data-Source Molecule ID	Data-Source
DB00479	drugbank
CHEBI:2637	chebi
AKN	rcsb_pdb
CHEMBL177	chembl
2985	surechembl
37768	pubchem
84319SGC3C	fdasrs
PD010002	probes_and_drugs
GABFOE	CCDC
1394	brenda
178950	brenda
HMDB0014622	hmdb
157	drugcentral
50237603	bindingdb
91426	bindingdb
The data in this table is sourced from UniChem at EBI.